Systems pharmacology-based drug discovery and active mechanism of natural products for coronavirus pneumonia (COVID-19): An example using flavonoids

[1]  Guohui Fan,et al.  6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2023, The Lancet.

[2]  J. Youn,et al.  Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms , 2021, Pharmacology & Therapeutics.

[3]  M. Shakibaei,et al.  Flavonoids against the SARS-CoV-2 induced inflammatory storm , 2021, Biomedicine & Pharmacotherapy.

[4]  T. Jiang,et al.  Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2 , 2021, International Journal of Biological Macromolecules.

[5]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[6]  V. Patravale,et al.  A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2 , 2020, Computers in Biology and Medicine.

[7]  Hamed A. El‐Serehy,et al.  Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study , 2020, Saudi Journal of Biological Sciences.

[8]  M. Michael Gromiha,et al.  Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19 , 2020, Computers in Biology and Medicine.

[9]  Mainak Biswas,et al.  COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review , 2020, Computers in Biology and Medicine.

[10]  Kunqian Yu,et al.  Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients , 2020, Acta Pharmacologica Sinica.

[11]  G. Russo,et al.  Roles of flavonoids against coronavirus infection , 2020, Chemico-Biological Interactions.

[12]  L. Wiedemann,et al.  Natural products' role against COVID-19 , 2020, RSC advances.

[13]  Hammad Naveed,et al.  Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach , 2020, Computers in Biology and Medicine.

[14]  Z. Bian,et al.  Bioactive natural compounds against human coronaviruses: a review and perspective , 2020, Acta Pharmaceutica Sinica B.

[15]  R. Kumar,et al.  Potential of Flavonoid-Inspired Phytomedicines against COVID-19 , 2020, Molecules.

[16]  T. Hung,et al.  Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs. , 2020, Journal of natural products.

[17]  U. Rajendra Acharya,et al.  Automated detection of COVID-19 cases using deep neural networks with X-ray images , 2020, Computers in Biology and Medicine.

[18]  Hualiang Jiang,et al.  Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease , 2020, Science.

[19]  H. Ashida,et al.  Kaempferol modulates TCDD- and t-BHQ-induced drug-metabolizing enzymes and luteolin enhances this effect. , 2020, Food & function.

[20]  Kunqian Yu,et al.  Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro , 2020, bioRxiv.

[21]  Jing Shi,et al.  Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan , 2020, Journal of Allergy and Clinical Immunology.

[22]  B. Robson,et al.  COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance , 2020, Computers in Biology and Medicine.

[23]  André Machado Siqueira,et al.  Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. , 2020, JAMA network open.

[24]  Linqi Zhang,et al.  Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor , 2020, Nature.

[25]  David J Newman,et al.  Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. , 2020, Journal of natural products.

[26]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[27]  Ai-Hua Zhang,et al.  Traditional Chinese medicine for COVID-19 treatment , 2020, Pharmacological Research.

[28]  B. Robson,et al.  Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus , 2020, Computers in Biology and Medicine.

[29]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[30]  W. Liang,et al.  Clinical characteristics of 2019 novel coronavirus infection in China , 2020, medRxiv.

[31]  D. Shin,et al.  Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro , 2020, Journal of enzyme inhibition and medicinal chemistry.

[32]  Gaohua Wang,et al.  Wogonin improves functional neuroprotection for acute cerebral ischemia in rats by promoting angiogenesis via TGF-β1. , 2019, Annals of translational medicine.

[33]  G. Ji,et al.  Recent progress regarding kaempferol for the treatment of various diseases , 2019, Experimental and therapeutic medicine.

[34]  Olivier Michielin,et al.  SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules , 2019, Nucleic Acids Res..

[35]  Olga Tanaseichuk,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[36]  Chunfeng Ma,et al.  YaTCM: Yet another Traditional Chinese Medicine Database for Drug Discovery , 2018, Computational and structural biotechnology journal.

[37]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[38]  The UniProt Consortium,et al.  UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..

[39]  Wei Zhang,et al.  ETCM: an encyclopaedia of traditional Chinese medicine , 2018, Nucleic Acids Res..

[40]  P. Zhou,et al.  Inhibition of α-glucosidase and α-amylase by flavonoid glycosides from Lu'an GuaPian tea: molecular docking and interaction mechanism. , 2018, Food & function.

[41]  A. Khalatbary,et al.  The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection , 2018, Nutritional neuroscience.

[42]  Giancarlo Mauri,et al.  MTGO: PPI Network Analysis Via Topological and Functional Module Identification , 2018, Scientific Reports.

[43]  J. Rom,et al.  Stimulation of chemokines in human endometrial stromal cells by tumor necrosis factor-α and interferon-γ is similar under apoptotic and non-apoptotic conditions , 2018, Archives of Gynecology and Obstetrics.

[44]  Y. H. Kim,et al.  Kushenol A and 8-prenylkaempferol, tyrosinase inhibitors, derived from Sophora flavescens , 2018, Journal of enzyme inhibition and medicinal chemistry.

[45]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[46]  A. Filippini,et al.  Naringenin Impairs Two-Pore Channel 2 Activity And Inhibits VEGF-Induced Angiogenesis , 2017, Scientific Reports.

[47]  Q. Guo,et al.  Overview of Oroxylin A: A Promising Flavonoid Compound , 2016, Phytotherapy research : PTR.

[48]  Tsippi Iny Stein,et al.  The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses , 2016, Current protocols in bioinformatics.

[49]  Christopher A Lipinski,et al.  Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions. , 2016, Advanced drug delivery reviews.

[50]  Yong Wang,et al.  BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine , 2016, Scientific Reports.

[51]  W. Xiao,et al.  Anti-osteoporosis effect of Epimedium via an estrogen-like mechanism based on a system-level approach. , 2016, Journal of ethnopharmacology.

[52]  Gang Fu,et al.  PubChem Substance and Compound databases , 2015, Nucleic Acids Res..

[53]  J. Cho,et al.  Fisetin Suppresses Macrophage-Mediated Inflammatory Responses by Blockade of Src and Syk , 2015, Biomolecules & therapeutics.

[54]  C. Shin,et al.  Antithrombotic Activities of Luteolin In Vitro and In Vivo , 2015, Journal of biochemical and molecular toxicology.

[55]  K. Kawabata,et al.  Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability. , 2015, Food & function.

[56]  W. Xiao,et al.  Systems pharmacology-based drug discovery for marine resources: an example using sea cucumber (Holothurians). , 2015, Journal of ethnopharmacology.

[57]  J. Duarte,et al.  Modulation of nitric oxide by flavonoids. , 2014, Food & function.

[58]  Cheng Peng,et al.  Puerarin: A Review of Pharmacological Effects , 2014, Phytotherapy research : PTR.

[59]  Kai Zhu,et al.  Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring , 2014, J. Chem. Inf. Model..

[60]  K. Lee,et al.  Recovery effect of onion peel extract against H2 O2 -induced inhibition of gap-junctional intercellular communication is mediated through quercetin. , 2014, Journal of food science.

[61]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[62]  D. Reinhold,et al.  DPP4-directed therapeutic strategies for MERS-CoV , 2014, The Lancet Infectious Diseases.

[63]  D. Gfeller,et al.  Shaping the interaction landscape of bioactive molecules , 2013, Bioinform..

[64]  M. Korgaonkar,et al.  GSK3B and MAPT Polymorphisms Are Associated with Grey Matter and Intracranial Volume in Healthy Individuals , 2013, PLoS ONE.

[65]  Shao Li,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application. , 2013, Chinese journal of natural medicines.

[66]  Zhao Fang,et al.  TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..

[67]  Hua Yu,et al.  A Novel Chemometric Method for the Prediction of Human Oral Bioavailability , 2012, International journal of molecular sciences.

[68]  G. Manda,et al.  Quercetin and epigallocatechin gallate effects on the cell membranes biophysical properties correlate with their antioxidant potential. , 2012, General physiology and biophysics.

[69]  Shun-Fa Yang,et al.  Erratum to: Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway , 2011, Archives of Toxicology.

[70]  M. Mezei,et al.  Molecular docking: a powerful approach for structure-based drug discovery. , 2011, Current computer-aided drug design.

[71]  M. Clifford,et al.  Dietary phenolics: chemistry, bioavailability and effects on health. , 2009, Natural product reports.

[72]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[73]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[74]  Yong Yang,et al.  Anti-hepatitis B virus activity of wogonin in vitro and in vivo. , 2007, Antiviral research.

[75]  Z. Nowakowska.  A review of anti-infective and anti-inflammatory chalcones. , 2007, European journal of medicinal chemistry.

[76]  Gary Williamson,et al.  Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. , 2004, Mutation research.

[77]  Liliana Jiménez,et al.  Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.

[78]  Saurabh Menon,et al.  ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis , 2004, Journal of Biological Chemistry.

[79]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[80]  B. Havsteen,et al.  The biochemistry and medical significance of the flavonoids. , 2002, Pharmacology & therapeutics.

[81]  D. Birt,et al.  Dietary agents in cancer prevention: flavonoids and isoflavonoids. , 2001, Pharmacology & therapeutics.

[82]  E. Middleton,et al.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. , 2000, Pharmacological reviews.

[83]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[84]  Yuko Sato,et al.  (-)-epigallocatechin-3-gallate , 2014 .

[85]  J. R. Kanwar,et al.  Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). , 2011, Current medicinal chemistry.

[86]  V. Sharma,et al.  Flavonoids as nutraceuticals. A review , 2010 .

[87]  Hyun Pyo Kim,et al.  Anti-inflammatory plant flavonoids and cellular action mechanisms. , 2004, Journal of pharmacological sciences.

[88]  F. Tomás-Barberán,et al.  Flavonoids in Food and Their Health Benefits , 2004, Plant foods for human nutrition.

[89]  Susumu Goto,et al.  The KEGG resource for deciphering the genome , 2004, Nucleic Acids Res..

[90]  Fumiyoshi Yamashita,et al.  In silico approaches for predicting ADME properties of drugs. , 2004, Drug metabolism and pharmacokinetics.

[91]  Gary D Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[92]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.

[93]  H. Berman,et al.  Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank , 2022 .